BlackRock’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-401,088
| Closed | -$251K | – | 5298 |
|
2020
Q4 | $251K | Buy |
401,088
+2,040
| +0.5% | +$1.28K | ﹤0.01% | 4363 |
|
2020
Q3 | $212K | Buy |
399,048
+24
| +0% | +$13 | ﹤0.01% | 4297 |
|
2020
Q2 | $274K | Sell |
399,024
-127,982
| -24% | -$87.9K | ﹤0.01% | 4229 |
|
2020
Q1 | $396K | Buy |
527,006
+1,170
| +0.2% | +$879 | ﹤0.01% | 4025 |
|
2019
Q4 | $794K | Sell |
525,836
-314
| -0.1% | -$474 | ﹤0.01% | 4002 |
|
2019
Q3 | $779K | Sell |
526,150
-4,099
| -0.8% | -$6.07K | ﹤0.01% | 4010 |
|
2019
Q2 | $684K | Sell |
530,249
-2,139,233
| -80% | -$2.76M | ﹤0.01% | 4062 |
|
2019
Q1 | $6.97M | Sell |
2,669,482
-63,929
| -2% | -$167K | ﹤0.01% | 3251 |
|
2018
Q4 | $4.51M | Buy |
2,733,411
+610,660
| +29% | +$1.01M | ﹤0.01% | 3400 |
|
2018
Q3 | $10.3M | Buy |
2,122,751
+31,469
| +2% | +$153K | ﹤0.01% | 3196 |
|
2018
Q2 | $13.1M | Buy |
2,091,282
+255,037
| +14% | +$1.59M | ﹤0.01% | 3079 |
|
2018
Q1 | $15.2M | Sell |
1,836,245
-25,102
| -1% | -$208K | ﹤0.01% | 2888 |
|
2017
Q4 | $19M | Buy |
1,861,347
+436,667
| +31% | +$4.45M | ﹤0.01% | 2787 |
|
2017
Q3 | $13M | Buy |
1,424,680
+448,341
| +46% | +$4.1M | ﹤0.01% | 2980 |
|
2017
Q2 | $7.13M | Buy |
976,339
+78,615
| +9% | +$574K | ﹤0.01% | 3301 |
|
2017
Q1 | $6.46M | Buy |
897,724
+897,241
| +185,764% | +$6.46M | ﹤0.01% | 3264 |
|
2016
Q4 | $3K | Hold |
483
| – | – | ﹤0.01% | 3559 |
|
2016
Q3 | $3K | Hold |
483
| – | – | ﹤0.01% | 3525 |
|
2016
Q2 | $4K | Buy |
483
+395
| +449% | +$3.27K | ﹤0.01% | 3515 |
|
2016
Q1 | $1K | Buy |
+88
| New | +$1K | ﹤0.01% | 3540 |
|